- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
US Binge Drinking: By the Numbers
Do you know what percentage of US adults report binge drinking? Or how much alcohol sold is consumed while binge drinking? Take our 12-question quiz to find out.
Binge drinking cuts a wide swath across US culture without regard for race, socioeconomic status, education level, age, or gender. Binge drinking is known to lead to many negative health and social consequences including acute impairment, unintentional injuries, interpersonal violence, suicide, alcohol poisoning, high blood pressure, and liver disease to name a few. A new study published in the American Journal of Preventive Medicine set out to assess disparities in binge drinking, information that could help plan effective prevention strategies at the state and national levels.The results include hundreds of very interesting numbers. See if you can choose the right ones in this 12-question quiz.
FDA Approves First Oral GLP-1 Receptor Agonist for Chronic Weight Management
December 23rd 2025The FDA approved once-daily oral semaglutide 25 mg for chronic weight management and long-term weight maintenance in adults with obesity or overweight, based on data from the OASIS clinical trial program.
Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1–Based Weight Loss
December 19th 2025Topline Phase 3 ATTAIN-MAINTAIN data show oral orforglipron met primary and key secondary endpoints for weight maintenance after prior GLP-1–based injectable therapy in adults with obesity.
